T. Rowe Price Associates’s Agenus AGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$177K Buy
57,656
+33,156
+135% +$119K ﹤0.01% 3039
2026
Q1
$82K Hold
24,500
﹤0.01% 3031
2025
Q4
$77K Buy
+24,500
New +$97.6K ﹤0.01% 2978
2025
Q2
Sell
-10,056
Closed -$16K 3060
2025
Q1
$16K Buy
+10,056
New +$29K ﹤0.01% 3013
2024
Q4
Sell
-21,072
Closed -$116K 3013
2024
Q3
$116K Buy
21,072
+231
+1% +$1.73K ﹤0.01% 2792
2024
Q2
$350K Buy
20,841
+2,945
+16% +$35.6K ﹤0.01% 2348
2024
Q1
$208K Buy
17,896
+6,153
+52% +$81.6K ﹤0.01% 2606
2023
Q4
$195K Buy
11,743
+443
+4% +$7.34K ﹤0.01% 2553
2023
Q3
$256K Buy
11,300
+1,446
+15% +$41K ﹤0.01% 2406
2023
Q2
$316K Buy
9,854
+516
+6% +$16.5K ﹤0.01% 2339
2023
Q1
$279K Sell
9,338
-388
-4% -$16.4K ﹤0.01% 2381
2022
Q4
$458K Buy
9,726
+377
+4% +$19.2K ﹤0.01% 2168
2022
Q3
$377K Buy
9,349
+1,040
+13% +$53K ﹤0.01% 2270
2022
Q2
$316K Buy
8,309
+1,480
+22% +$53.7K ﹤0.01% 2420
2022
Q1
$330K Buy
6,829
+648
+10% +$35K ﹤0.01% 2518
2021
Q4
$391K Buy
6,181
+3,909
+172% +$308K ﹤0.01% 2499
2021
Q3
$234K Sell
2,272
-5
-0.2% -$565 ﹤0.01% 2666
2021
Q2
$245K Buy
2,277
+327
+17% +$24.5K ﹤0.01% 2652
2021
Q1
$104K Buy
1,950
+32
+2% +$2.31K ﹤0.01% 2777
2020
Q4
$120K Sell
1,918
-59,136
-97% -$4.39M ﹤0.01% 2614
2020
Q3
$4.79M Sell
61,054
-34,147
-36% -$2.66M ﹤0.01% 1408
2020
Q2
$7.34M Buy
95,201
+91,675
+2,600% +$5.49M ﹤0.01% 1344
2020
Q1
$170K Buy
3,526
+34
+1% +$2.13K ﹤0.01% 2345
2019
Q4
$279K Buy
3,492
+219
+7% +$14.7K ﹤0.01% 2338
2019
Q3
$166K Buy
3,273
+1,604
+96% +$85.8K ﹤0.01% 2404
2019
Q2
$98K Sell
1,669
-2,548
-60% -$139K ﹤0.01% 2481
2019
Q1
$246K Buy
4,217
+16
+0.4% +$993 ﹤0.01% 2354
2018
Q4
$196K Sell
4,201
-1,644
-28% -$68.6K ﹤0.01% 2413
2018
Q3
$246K Buy
5,845
+2,307
+65% +$90.8K ﹤0.01% 2412
2018
Q2
$158K Buy
3,538
+5
+0.1% +$337 ﹤0.01% 2488
2018
Q1
$327K Buy
3,533
+7
+0.2% +$622 ﹤0.01% 2260
2017
Q4
$226K Buy
3,526
+1,972
+127% +$151K ﹤0.01% 2384
2017
Q3
$135K Hold
1,554
﹤0.01% 2469
2017
Q2
$119K Buy
1,554
+662
+74% +$46.6K ﹤0.01% 2460
2017
Q1
$66K Hold
892
﹤0.01% 2524
2016
Q4
$72K Buy
+892
New +$87.6K ﹤0.01% 2497

Other funds holding AGEN

T. Rowe Price Associates's AGEN Position: Q2 2026 in Review

T. Rowe Price Associates increased its Agenus (AGEN) stake by 135% in Q2 2026, buying an estimated $119K and bringing the position to 57,656 shares worth $177K. The position accounts for ﹤0.01% of the portfolio, ranked #3039.

T. Rowe Price Associates first reported a position in AGEN in Q4 2016 and has held it in 36 quarters since. The position peaked at $7.34M in Q2 2020. 103 funds tracked by Wall St. Rank hold AGEN as of Q2 2026.

  • T. Rowe Price Associates held 57,656 shares of Agenus worth $177K as of Q2 2026.
  • T. Rowe Price Associates bought 33,156 Agenus shares in Q2 2026, an estimated $119K.
  • Agenus made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #3039 holding.
  • T. Rowe Price Associates first reported a position in Agenus in Q4 2016 and has held it in 36 quarters since.
  • T. Rowe Price Associates's Agenus position peaked at $7.34M in Q2 2020.
  • 103 funds tracked by Wall St. Rank held Agenus as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.